274 related articles for article (PubMed ID: 25882617)
1. Waldenström macroglobulinemia: What a hematologist needs to know.
Kapoor P; Paludo J; Vallumsetla N; Greipp PR
Blood Rev; 2015 Sep; 29(5):301-19. PubMed ID: 25882617
[TBL] [Abstract][Full Text] [Related]
2. Waldenstrom Macroglobulinemia: Familial Predisposition and the Role of Genomics in Prognosis and Treatment Selection.
Kapoor P; Paludo J; Ansell SM
Curr Treat Options Oncol; 2016 Mar; 17(3):16. PubMed ID: 26942591
[TBL] [Abstract][Full Text] [Related]
3. Waldenstrom's macroglobulinemia in the era of immunotherapy.
Vaxman I; Gertz M
Leuk Lymphoma; 2020 Jun; 61(6):1292-1304. PubMed ID: 31960730
[TBL] [Abstract][Full Text] [Related]
4. Waldenstrom Macroglobulinemia: Genomic Aberrations and Treatment.
Kapoor P; Ansell SM; Braggio E
Cancer Treat Res; 2016; 169():321-361. PubMed ID: 27696269
[TBL] [Abstract][Full Text] [Related]
5. Waldenström macroglobulinemia.
Kasi PM; Ansell SM; Gertz MA
Clin Adv Hematol Oncol; 2015 Jan; 13(1):56-66. PubMed ID: 25679974
[TBL] [Abstract][Full Text] [Related]
6. Clinical application of genomics in Waldenström macroglobulinemia.
Branagan AR; Lei M; Treon SP; Castillo JJ
Leuk Lymphoma; 2021 Aug; 62(8):1805-1815. PubMed ID: 33569985
[TBL] [Abstract][Full Text] [Related]
7. Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance.
Varettoni M; Zibellini S; Defrancesco I; Ferretti VV; Rizzo E; Malcovati L; Gallì A; Porta MGD; Boveri E; Arcaini L; Candido C; Paulli M; Cazzola M
Haematologica; 2017 Dec; 102(12):2077-2085. PubMed ID: 28983055
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and indications for treatment of Waldenström's Macroglobulinemia.
Kyle RA; Ansell SM; Kapoor P
Best Pract Res Clin Haematol; 2016 Jun; 29(2):179-186. PubMed ID: 27825464
[TBL] [Abstract][Full Text] [Related]
10. Lymphoplasmacytic lymphoma and Waldenström macroglobulinemia.
Naderi N; Yang DT
Arch Pathol Lab Med; 2013 Apr; 137(4):580-5. PubMed ID: 23544948
[TBL] [Abstract][Full Text] [Related]
11. Waldenström Macroglobulinemia: Review of Pathogenesis and Management.
Yun S; Johnson AC; Okolo ON; Arnold SJ; McBride A; Zhang L; Baz RC; Anwer F
Clin Lymphoma Myeloma Leuk; 2017 May; 17(5):252-262. PubMed ID: 28366781
[TBL] [Abstract][Full Text] [Related]
12. Novel treatment options for Waldenström macroglobulinemia.
Leblebjian H; Agarwal A; Ghobrial I
Clin Lymphoma Myeloma Leuk; 2013 Sep; 13 Suppl 2(0 2):S310-6. PubMed ID: 24290218
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Tools of Waldenströms Macroglobulinemia - Best Possibilities for Non-invasive and Long-term Disease Monitoring.
Growkova K; Kufová Z; Sevcikova T; Filipová J; Kascak M; Jelínek T; Grosicki S; Barchnicka A; Roziaková Ľ; Mistrík M; Simicek M; Hájek R
Klin Onkol; 2017; 30(Supplementum2):81-91. PubMed ID: 28903575
[TBL] [Abstract][Full Text] [Related]
14. Bortezomib as a treatment option in patients with Waldenström macroglobulinemia.
Dimopoulos MA; Chen C; Kastritis E; Gavriatopoulou M; Treon SP
Clin Lymphoma Myeloma Leuk; 2010 Apr; 10(2):110-7. PubMed ID: 20371443
[TBL] [Abstract][Full Text] [Related]
15. Neurological manifestations of Waldenström macroglobulinemia.
Baehring JM; Hochberg EP; Raje N; Ulrickson M; Hochberg FH
Nat Clin Pract Neurol; 2008 Oct; 4(10):547-56. PubMed ID: 18813229
[TBL] [Abstract][Full Text] [Related]
16. Are you sure this is Waldenstrom macroglobulinemia?
Ghobrial IM
Hematology Am Soc Hematol Educ Program; 2012; 2012():586-94. PubMed ID: 23233639
[TBL] [Abstract][Full Text] [Related]
17. Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.
Vitolo U; Ferreri AJ; Montoto S
Crit Rev Oncol Hematol; 2008 Aug; 67(2):172-85. PubMed ID: 18499469
[TBL] [Abstract][Full Text] [Related]
18. Genomic abnormalities of Waldenström macroglobulinemia and related low-grade B-cell lymphomas.
Braggio E; Fonseca R
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):198-201. PubMed ID: 23477936
[TBL] [Abstract][Full Text] [Related]
19. Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations.
King RL; Gonsalves WI; Ansell SM; Greipp PT; Frederick LA; Viswanatha DS; He R; Kyle RA; Gertz MA; Kapoor P; Morice WG; Howard MT
Am J Clin Pathol; 2016 Jun; 145(6):843-51. PubMed ID: 27329639
[TBL] [Abstract][Full Text] [Related]
20. Management of Waldenström Macroglobulinemia in Limited-Resource Settings.
Riva E; Tietsche de Moraes Hungría V; Chiattone C; Martínez-Cordero H
Hematol Oncol Clin North Am; 2023 Aug; 37(4):801-807. PubMed ID: 37258356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]